The ASCO Post — ASCO, Friends of Cancer Research Applaud FDA Draft Guidance
New Guidance Seeks to Broaden Cancer Clinical Trials Eligibility Criteria, Expand Participation The Association for Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) are applauding efforts by the U.S. Food and Drug Administration (FDA) to broaden eligibility criteria for cancer clinical trials in order to include more diverse patient populations. In joint comments submitted on June…